First Manhattan’s Chemed CHE Stock Holding History

First Manhattan’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-23	Closed	-$11.7K	–	1555
2022 Q4	$11.7K	Buy	+23	New	+$11.2K	﹤0.01%	1223
2016 Q3	–	Sell	-65	Closed	-$8K	–	1394
2016 Q2	$8K	Buy	+65	New	+$8.62K	﹤0.01%	1255

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

First Manhattan's CHE Position: Q1 2023 in Review

First Manhattan sold out of Chemed (CHE) in Q1 2023, closing a stake of 23 shares — an estimated $11.7K sold.

First Manhattan first reported a position in CHE in Q2 2016 and held it in 2 quarters. The position peaked at $11.7K in Q4 2022. 459 funds tracked by Wall St. Rank hold CHE as of Q1 2023.

First Manhattan reported no remaining Chemed position as of Q1 2023 after selling out during the quarter.
First Manhattan sold 23 Chemed shares in Q1 2023, an estimated $11.7K.
First Manhattan first reported a position in Chemed in Q2 2016 and held it in 2 quarters.
First Manhattan's Chemed position peaked at $11.7K in Q4 2022.
459 funds tracked by Wall St. Rank held Chemed as of Q1 2023.

Based on First Manhattan's 13F filing for Q1 2023, filed 15 May 2023.